DXC Technology Co
DXC Technology provides software, services and solutions to global enterprises and public sector organizations. Its three segments are Consulting & Engineering Services, Global Infrastructure Services, and Insurance Software & Services. Consulting & Engineering Services offers software engineering, consulting, data analytics and application solutions to help businesses modernize operations. Global Infrastructure Services designs, migrates and manages data center, mainframe, cloud and network environments, and provides IT operations, workplace and business process services. Insurance Software & Services supplies software and services to life and wealth, property and casualty, and reinsurance providers. DXC supports clients through a global direct sales force. Its offerings include consulting, software, managed infrastructure and business process services. The company has approximately 115,000 employees in 60 countries. It was formed on April 1, 2017 by the merger of CSC and HPES.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $DXC in the last 30 days.
See all $DXC insider activity →Accenture (NYSE:ACN) and peers reported Q3 earnings, with Accenture beating revenue estimates by 3.5% and Gartner (NYSE:IT) outperforming by 1.2%. DXC (NYSE:DXC) missed EPS guidance. IBM (NYSE:IBM) and Kyndryl (NYSE:KD) also reported, with mixed results. IT services & consulting stocks are up 11.4% on average since earnings.
Morgan Stanley kept DXC Technology at Equal-Weight, raising its price target to $12 from $9, a 33.3% increase. This implies a 19.9% downside from the Oct 30 close of $14.98.
JP Morgan kept its Underweight rating on DXC Technology but increased its price target to $13 from $12, suggesting a 13.2% downside from the last close of $14.98.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning DXC (DXC Technology Co). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent DXC coverage spans earnings and financial news.
Weak guidance may weigh on the stock despite the revenue beat.
The PT raise can support near-term sentiment, but the article provides no new company fundamentals beyond the analyst call.
Analyst upgrade may lift sentiment and support a modest price rally.
The filing introduces new financial data that may affect investor sentiment.
Guidance downgrade and AI‑strategy rollout suggest near‑term revenue pressure.
AlphAI scores every news story that mentions DXC with an AI model for sentiment and relevance, and aggregates insider trades from DXC Technology Co's SEC EDGAR Form 4 filings. Figures refresh continuously.
Accenture (NYSE:ACN) and peers reported Q3 earnings, with Accenture beating revenue estimates by 3.5% and Gartner (NYSE:IT) outperforming by 1.2%. DXC (NYSE:DXC) missed EPS guidance. IBM (NYSE:IBM) and Kyndryl (NYSE:KD) also reported, with mixed results. IT services & consulting stocks are up 11.4% on average since earnings.
Morgan Stanley kept DXC Technology at Equal-Weight, raising its price target to $12 from $9, a 33.3% increase. This implies a 19.9% downside from the Oct 30 close of $14.98.
JP Morgan kept its Underweight rating on DXC Technology but increased its price target to $13 from $12, suggesting a 13.2% downside from the last close of $14.98.
DXC Technology filed its quarterly report (10-Q) with the SEC on October 30, 2026. The filing includes periodic financial reports and exhibits. Investors can review the details for insights into the company's financial performance.
DXC Technology CEO Raul Fernandez reported progress in commercializing AI, with 5,700+ employees certified and Oasis platform usage up sixfold. The company is focusing on AI trust, safety, and smaller, faster agentic AI deals. DXC adjusted full-year guidance due to weaker core sales but exceeded quarterly revenue and earnings estimates. Fernandez also confirmed discussions about a potential sale of the insurance business to create shareholder value.
DXC Technology (DXC) reported Q2 2027 revenue beating guidance but lowered full-year revenue outlook to a 5-5.5% decline due to weak bookings and pipeline conversion. Adjusted EBIT margin fell to 6.2%, and non-GAAP EPS dropped to $0.67. The company faces deal delays and increased competition, particularly in the Americas and UKI. DXC is taking cost actions to protect margins but revenue decline may pressure future profitability.
Susquehanna kept DXC Technology at Neutral but raised its price target to $12 from $10, a 20% increase. This implies a 21.2% downside from the Oct 29 close of $15.23, according to the firm.
DXC Technology (DXC) anticipates a 5% to 5.5% drop in organic revenue by fiscal year 2027, according to the company. The firm is considering strategic actions, including insurance options, to address the projected decline.
DXC Technology reported Q2 FY27 revenue of $7.45 billion, down 4% YoY, with adjusted EBIT margin of 6.2% and non-GAAP EPS of $0.15. The company expects Q3 organic revenue to drop 6% YoY. CEO Raul Fernandez highlighted progress in AI-based solutions. DXC also announced potential sale of its insurance business. Full-year revenue is projected to decline 5-5.5% YoY. (299 characters)
Multiple companies saw unusual option activity on October 23rd, including DXC Technology, Cameco, Vertiv Holdings, Nike, SK Hynix, Redwire, Moderna, American Express, Kroger, and Roblox. DXC Technology is reportedly in talks to sell its insurance software unit for $2.4B, causing its stock to rise 10%.
